Vanderbilt Ingram Cancer Center
2220 Pierce Ave.
Nashville, TN 37232
World renowned endocrine tumor expert Kjell Oberg and Vanderbilt are working together to bring to the U.S. the very latest advances in the treatment of neuroendocrine cancer.
In October, Oberg, M.D., Ph.D., was appointed adjunct professor of Surgery, working directly with Eric H. Liu, M.D., director of the Vanderbilt Neuroendocrine Center.
“His incredible insights and collaboration will surely position Vanderbilt as a U.S. leader in the treatment of this disease,” Liu said.
Prior to opening the center, Liu studied with Oberg in Sweden, where he chairs the Centre of Excellence for Endocrine Tumors at Uppsala Hospital.
“Kjell’s resume is truly a modern history of neuroendocrine cancer,” said Liu, assistant professor of Surgery in the division of Surgical Oncology & Endocrine Surgery. “His affiliation with Vanderbilt will bring decades of experience and a view of cutting-edge treatments for neuroendocrine cancer,” he said.